R1 - Expand new drug markets for tuberculosis (endTB)
R3 - HIV/HCV Drug affordability project (Coalition Internationale Sida)
R4 - Ensuring access to the HCV treatment revolution for HCV/HIV co-infected patients
R5 - Access to treatment for people living with HIV in middle-income countries
R8 - Achieving catalytic expansion of Seasonal Malaria Chemoprevention services in the Sahel
R9 - LYNX p24 Establishing and sustaining a market-based intervention for early-infant diagnosis of HIV at the point of care
